Seppo Pyrhönen - Concepedia

Author

Seppo Pyrhönen

Also Known As

S O Pyrhönen, S Pyrhonen, S Pyrhönen, S. O. Pyrhönen, S. PYRHONEN, S. PYRHÖNEN, S. PYRHöNEN, S. Pyrhonen, S. Pyrhönen, S.O. Pyrhönen

287

Publications

11.6K

Citations

H-Index

146

Concepts

All Affiliations

Helsinki University Hospital Turku University Hospital University of Turku University of Helsinki University of Eastern Finland

About

Seppo Pyrhönen is an author at Helsinki University Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	93	6.1K
2	Health Sciences	8	8	186
3	Nursing	3	3	47
4	Arts	2	2	28
5	Education	1	1	19

Seppo Pyrhönen

174

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer David Cunningham, Seppo Pyrhönen, R.D. James, The Lancet Gastrointestinal OncologyMedicineCancer ManagementColorectal CancerMetastatic Colorectal Cancer	1998	1.3K
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Seppo Pyrhönen, Tapio Kuitunen, Paul Nyandoto, British Journal of Cancer Surgical OncologyOncologyGastrointestinal OncologyNon-resectable Gastric CancerCancer Management	1995	794
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius, Journal of Clinical Oncology	2012	527
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis Karí Syrjänen, Stina Syrjänen, Matti A. Lamberg, International Journal of Oral Surgery Immunohistochemical EvidenceHuman Papillomavirus VaccinesOral CavityImmunologyOral Biology	1983	464
Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer Seppo Pyrhönen, Eeva Salminen, Mirja Ruutu, Journal of Clinical Oncology	1999	441
BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Rajiv Kumar, Sabrina Angelini, Kamila Czene, PubMed	2003	207
High Serum Levels of Matrix Metalloproteinase-9 and Matrix Metalloproteinase-1 Are Associated with Rapid Progression in Patients with Metastatic Melanoma Johanna Nikkola, Pia Vihinen, Meri‐Sisko Vuoristo, Clinical Cancer Research	2005	195
Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. A. Niiranen, S. Niitamo-Korhonen, Mauri Kouri, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdjuvant ChemotherapyPathologySurgery	1992	188
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus Tommi Kainu, Suh‐Hang Hank Juo, Richard Desper, Proceedings of the National Academy of Sciences	2000	185
A prognostic model and staging for metastatic uveal melanoma Sebastian Eskelin, Seppo Pyrhönen, Marjo Hahka‐Kemppinen, Cancer	2003	165

Page 1